DENVER, Feb. 24, 2015 /PRNewswire/ -- DaVita Kidney Care, a division of DaVita HealthCare Partners Inc. (NYSE: DVA) and a leading provider of kidney care services, today announced that Mahesh Krishnan, M.D., MPH, MBA, FASN, will serve as the company's international chief medical officer (CMO) and group vice president of research and development to implement global clinical initiatives.

DaVita HealthCare Partners Inc.

"I'm excited to have the opportunity to work with our talented group of global nephrologists and teammates to help positively impact worldwide patient outcomes," Krishnan said. "Developing an infrastructure to share best practices, improve clinical outcomes and cross-pollinate clinical research is our top priority."

Krishnan previously served as DaVita Kidney Care's vice president of clinical research, innovation and public policy. Prior to joining DaVita Kidney Care in 2009, Krishnan worked in various nephrology leadership positions with Amgen, heading up global health economics and outcomes research for nephrology. He also was responsible for overseeing the Dialysis Outcomes Practice Pattern Study, an international registry of hemodialysis patients. 

"Dr. Krishnan has vast experience and a proven track record of success domestically and internationally," said Dennis Kogod, CEO of DaVita Kidney Care's international business and president of HealthCare Partners. "His expertise will enhance our commitment to clinical differentiation and help bring quality care to our patients around the world."

DaVita Kidney Care is committed to clinical excellence and has improved patient outcomes in the U.S. for 15 consecutive years and counting, the benefits of which include fewer hospitalizations and better health-related quality of life. In fact, DaVita Kidney Care has the highest performance ranking in the first-ever Five-Star ranking system for dialysis providers, outperforming the industry by nearly 200 percent.

DaVita Kidney Care has established successful operations in 10 countries outside of the U.S. In 2014, DaVita Kidney Care signed a tender from the Kingdom of Saudi Arabia's Ministry of Health to treat half of the nearly 10,000 patients currently under the ministry's care.

DaVita Kidney Care in India also received recognition from India Healthcare Excellence Awards as the Dialysis Service Provider Company of the Year in the specialty chain category by Frost and Sullivan.

Finally, the Jalan Tun Razak dialysis center in Kuala Lumpur, Malaysia, became the first stand-alone dialysis center in the country to receive a four-year accreditation in chronic dialysis treatment from the Malaysian Society for Quality in Health.

For more information on DaVita Kidney Care's international operations, visit DaVita.com/About/International.

About DaVita Kidney Care
DaVita Kidney Care is a division of DaVita HealthCare Partners Inc., a Fortune 500(r) company that, through its operating divisions, provides a variety of health care services to patient populations throughout the United States and abroad. A leading provider of dialysis services in the United States, DaVita Kidney Care treats patients with chronic kidney failure and end stage renal disease. DaVita Kidney Care strives to improve patients' quality of life by innovating clinical care, and by offering integrated treatment plans, personalized care teams and convenient health-management services. As of Dec. 31, 2014, DaVita Kidney Care operated or provided administrative services at 2,179 outpatient dialysis centers located in the United States serving approximately 170,000 patients. The company also operated 91 outpatient dialysis centers located in 10 countries outside the United States. DaVita Kidney Care supports numerous programs dedicated to creating positive, sustainable change in communities around the world. The company's leadership development initiatives and social responsibility efforts have been recognized by Fortune, Modern Healthcare, Newsweek and WorldBlu. For more information, please visit DaVita.com.

DaVita, HealthCare Partners and DaVita HealthCare Partners are trademarks or registered trademarks of DaVita HealthCare Partners Inc.

Contact Information
Media:
Ashley Henson
303-876-6498
Ashley.Henson@davita.com

Logo - http://photos.prnewswire.com/prnh/20140318/DC85712LOGO

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/davita-kidney-care-announces-its-first-chief-medical-officer-for-international-operations-300039219.html

SOURCE DaVita HealthCare Partners

Copyright 2015 PR Newswire

DaVita (NYSE:DVA)
Historical Stock Chart
From Mar 2024 to Apr 2024 Click Here for more DaVita Charts.
DaVita (NYSE:DVA)
Historical Stock Chart
From Apr 2023 to Apr 2024 Click Here for more DaVita Charts.